advertisement
8
Showing records 1 to 8 | Display all abstracts from55601 Improvement in glaucoma patient quality of life by therapy switch to preservative-free timolol/dorzolamide fixed combination
Abegão Pinto L; Vandewalle E; Gerlier L; Stalmans I;
Ophthalmologica 2014; 231: 166-171
55695 Current status of visual field examination in Andalusia, Spain: The SICVA Study
Benítez-Del-Castillo J; Regi T;
European Journal of Ophthalmology 2013; 0: 0
55425 Combining spectral domain optical coherence tomography structural parameters for the diagnosis of glaucoma with early visual field loss
Mwanza JC; Warren JL; Budenz DL;
Investigative Ophthalmology and Visual Science 2013; 54: 8393-8400
55256 Retinal nerve fiber layer thickness in a population of 12-year-old children in central China measured by iVue-100 spectral-domain optical coherence tomography: the Anyang Childhood Eye Study
Zhu BD; Li SM; Li H; Liu LR; Wang Y; Yang Z; Li SY; Kang MT; Fu J; Qi YH; Zhan SY; Wang N;
Investigative Ophthalmology and Visual Science 2013; 54: 8104-8111
55539 External validation of the OHTS-EGPS model for predicting the 5-year risk of open-angle glaucoma in ocular hypertensives
Takwoingi Y; Botello AP; Burr JM; Azuara-Blanco A; Garway-Heath DF; Lemij HG; Sanders R; King AJ; Deeks JJ;
British Journal of Ophthalmology 2014; 98: 309-314
55201 The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics
Lascaratos G; Garway-Heath DF; Burton R; Bunce C; Xing W; Crabb DP; Russell RA; Shah A;
Ophthalmology 2013; 120: 2540-2545
55376 Safety and Efficacy of Benzalkonium Chloride-optimized Tafluprost in Japanese Glaucoma Patients With Existing Superficial Punctate Keratitis
Suzuki K; Teranishi S; Sagara T; Yoshino H; Nakayama M; Enoki M; Nuno Y; Hirano S; Wakuta M; Takahashi N; Tokuhisa K; Kondo Y; Shiraishi R; Ishida Y; Sonoda KH;
Journal of Glaucoma 2015; 24: e145-e150
55672 Changes in the morphological and functional patterns of the ocular surface in patients treated with prostaglandin analogues after the use of TSP 0.5%® preservative-free eyedrops: a prospective, multicenter study
Iester M; Oddone F; Fogagnolo P; Frezzotti P; Figus M;
Ophthalmic Research 2014; 51: 146-152
